Opus Genetics, Inc. · NASDAQ:IRD
Adage Capital Management, L.P. reported a 8.47% stake in Opus Genetics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 13, 2026
Adage Capital Management, L.P. reported a 8.47% stake in Opus Genetics, Inc., 6,029,775 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G).
- Stake
- 8.47%
- Shares
- 6,029,775
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 8.47% | 6,029,775 |
| Robert Atchinson | 8.47% | 6,029,775 |
| Phillip Gross | 8.47% | 6,029,775 |
Source
Related
- Opus Genetics, Inc.
- Adage Capital Management, L.P.
- Opus Genetics, Inc. shareholders
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026